Emergent Biosolutions EBS Finite-Lived Intangible Assets, Accumulated Amortization
Finite-Lived Intangible Assets, Accumulated Amortization at other companies
Other financials
Where this comes from
Reported directly by Emergent Biosolutions in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization.
The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Emergent Biosolutions's finite-lived intangible assets, accumulated amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Emergent Biosolutions's finite-lived intangible assets, accumulated amortization?
- Emergent Biosolutions (EBS) reported finite-lived intangible assets, accumulated amortization of $435.4M in Q1 2026.
- How has Emergent Biosolutions's finite-lived intangible assets, accumulated amortization changed year-over-year?
- Emergent Biosolutions's finite-lived intangible assets, accumulated amortization increased by 17.6% year-over-year, from $370.2M to $435.4M.
- What is the long-term trend for Emergent Biosolutions's finite-lived intangible assets, accumulated amortization?
- Over 5 years (2020 to 2025), Emergent Biosolutions's finite-lived intangible assets, accumulated amortization has grown at a 19.9% compound annual growth rate (CAGR), from $169M to $418.9M.